Player size: small large

ISHLTv_09 - Hepatitis C+ Donors for Heart Transplantation: Redefining High Risk

Oct 28, 2020 12:00pm ‐ Oct 28, 2020 1:30pm

Members: Free

Overview
Comments

An ISHLT 2020 Oral Session

This session provides the most current data on the status of heart transplantation from Hepatitis C positive donors, including effects on waitlist mortality, as well as post-transplant recipient outcomes, such as clearance of viremia, acute rejection, cardiac allograft vasculopathy, and overall survival.

Moderators:
Kelly Schlendorf, MD, Vanderbilt University, Nashville, TN, USA
Jignesh K. Patel, MD, PhD, Cedars-Sinai Heart Institute, Beverly Hills, CA, USA

Welcome and Program Panel Introduction
Kelly Schlendorf, MD

(268) Successful Transplantation of 96 Hepatitis C-positive Donor Hearts in the Era of Direct-Acting Antiviral Therapies
Kelly Schlendorf, MD, Vanderbilt University, Nashville, TN, USA

(269) HCV Seropositive Donors Positively Impact Heart Transplantation Rates and Waitlist Mortality without Compromising Outcomes
Peter J. Altshuler, MD, University of Pennsylvania, Philadelphia, PA, USA

(270) Intermediate Survival Outcomes after Heart Transplantation Using Donor HCV NAT Positive Hearts
Jonathan Nattiv, MD, Univ of Southern California, Los Angeles, CA, USA

(271) Outcomes of Heart Transplantation from Hepatitis C Seropositive Donors: An Updated Analysis of the United Network for Organ Sharing Registry
Selena S. Li, MD, Massachusetts General Hospital, Boston, MA, USA

(272) Magnitude of Viremia after Heart and Lung Transplantation from HCV Viremic Donors and Time to Clearance Based on Timing of Starting Therapy Post-Transplantation
Stacey Chen, MD, NYU Langone Health, New York, NY, USA

(273) Incidence of Acute Cellular Rejection in Heart Transplant Recipients from Hepatitis C Viremic Donors -- One-Year Follow-Up
Maxine W. Stachel, MD, NYU Langone Health, New York, NY, USA

(274) Cardiac Allograft Vasculopathy in Heart Transplant Recipients from Hepatitis C Viremic Donors
Bernard Kadosh, MD, NYU Langone Health, New York, NY, USA

Live Q & A Segment with all presenters
Led by Jignesh Patel, MD

ISHLT Advanced Heart Failure and Transplantation Interdisciplinary Network Update
Marta Farrero Torres, MD, PhD, Hospital Clinic de Barcelona, Barcelona, Spain
Chair, ISHLT Advanced Heart Failure and Transplantation Interdisciplinary Network Steering Committee

ISHLT Announcements
Greg Schultz, CEO, ISHLT, Addison, TX, USA

Speaker(s):

Kelly Schlendorf, MD, Nashville, TN, USA, Vanderbilt University Medical Center
Jignesh Patel, MD, PhD, Beverly Hills, CA, USA, Cedars Sinai Heart Institute
Peter Altshuler, MD, General Surgery Resident, Thomas Jefferson University<br>Post-doctoral Research Felllow, University of Pennsylvania<br>Philadelphia, PA, USA, University of Pennsylvania
Jonathan Nattiv, MD, Los Angeles, CA, USA, University of Southern California
Selena Li, MD, Boston, MA, USA, Massachusetts General Hospital
Stacey Chen, MD, New York, NY, USA, NYU Langone Health
Maxine Stachel, MD, New York, NY, USA, NYU Langone Health
Bernard Kadosh, MD, Assistant Professor<br>NYU Grossman School of Medicine<br>New York, NY, USA, NYU Langone Health
Marta Farrero Torres, MD, PhD, Barcelona, Spain, Hospital Clinic de Barcelona
Greg Schultz, CEO, Addison, TX, USA, International Society for Heart and Lung Transplantation

You must be logged in and own this session in order to post comments.